Cite
Basu B, Pandey R, Mahapatra TK, et al. WITHDRAWN: Efficacy and Safety of Mycophenolate Mofetil Versus Levamisole in Children and Adolescents With Idiopathic Nephrotic Syndrome: Results of a Randomized Clinical Trial. Am J Kidney Dis. 2015;doi: 10.1053/j.ajkd.2015.04.048.
Basu, B., Pandey, R., Mahapatra, T. K., Mondal, N., & Schaefer, F. (2015). WITHDRAWN: Efficacy and Safety of Mycophenolate Mofetil Versus Levamisole in Children and Adolescents With Idiopathic Nephrotic Syndrome: Results of a Randomized Clinical Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, . https://doi.org/10.1053/j.ajkd.2015.04.048
Basu, Biswanath, et al. "WITHDRAWN: Efficacy and Safety of Mycophenolate Mofetil Versus Levamisole in Children and Adolescents With Idiopathic Nephrotic Syndrome: Results of a Randomized Clinical Trial." American journal of kidney diseases : the official journal of the National Kidney Foundation vol. (2015). doi: https://doi.org/10.1053/j.ajkd.2015.04.048
Basu B, Pandey R, Mahapatra TK, Mondal N, Schaefer F. WITHDRAWN: Efficacy and Safety of Mycophenolate Mofetil Versus Levamisole in Children and Adolescents With Idiopathic Nephrotic Syndrome: Results of a Randomized Clinical Trial. Am J Kidney Dis. 2015 Jun 09; doi: 10.1053/j.ajkd.2015.04.048. Epub 2015 Jun 09. PMID: 26071057.
Copy
Download .nbib